Beijing drops COVID testing burden as wider easing beckons
Tests no longer needed for supermarkets, offices
Latest in a mix of nationwide easing steps
Curbs sparked widespread protests last month
New national rules due as soon as Weds - sources
By Ryan Woo and Martin Quin Pollard
BEIJING, Dec 6 (Reuters) - Residents of China's capital were allowed into parks, supermarkets, offices and airports without a negative COVID-19 test on Tuesday, the latest in a mix of easing steps nationwide after unprecedented protests against a tough zero-COVID policy.
"Beijing readies itself for life again," read a headline in the government-owned China Daily newspaper, adding that people were "gradually embracing" newfound freedoms.
Authorities have been loosening some of the world's toughest COVID curbs to varying degrees and softening their tone on the threat of the virus, in what many hope could herald a more pronounced shift towards normalcy three years into the pandemic.
"This might be the first step towards reopening," Hu Dongxu, 27, told Reuters as he swiped his travel card to enter a train station in Beijing, which has also dropped the need for tests to use the subway.
As they waited for news, some people, wary the virus might now spread faster, rushed to buy COVID antigen kits and fever medicine and market regulators issued warnings against hoarding and hiking prices.
Both of the city's airports also no longer require people to test to enter the terminal, state media reported, although there was no indication of a change to the rule for a negative test before boarding a flight.
The loosening of the rules comes after a string of protests last month that marked the biggest show of public discontent in mainland China since President Xi Jinping took power in 2012.
While rallies have subsided, throngs of students at a university in Nanjing city chanted at a protest on Monday against COVID policy on their campus, according to videos on Twitter. Reuters confirmed that the footage was taken at Nanjing Tech University.
China may announce 10 new easing measures as early as Wednesday, two sources with knowledge of the matter told Reuters.
The prospect of a relaxation has sparked optimism among investors that the world's second biggest economy would regather strength and help to boost global growth.
The Chinese yuan CNY=CFXS has risen about 5% against the dollar since early November on expectation of an eventual reopening of China's economy.
Screenshots of an article criticising China's the zero- COVID policy published by a health supervision body in Henan province were widely shared on social media on Tuesday, after it was censored following its publication.
The article posted on the WeChat page of the Zhumadian city health commission, criticised some "devastating" impacts caused by the policy and its sometimes "brutal" implementation.
But on the ground, many people have been slow to adapt to the changing rules. Commuter traffic in major cities such as Beijing and Chongqing has remained a fraction of normal levels.
Some people remain wary of catching the virus, especially the elderly, while there is concern about the strain the loosening may put on a fragile health system.
"My parents are still very cautious," said James Liu, 22, a student in Shenzhen city in the southern province of Guangdong, where authorities dropped testing requirements to get into the family's residential compound.
China has reported 5,235 COVID-related deaths as of Monday, but some experts have warned that toll could rise above 1 million if the exit is too hasty.
Analysts at Nomura estimate that areas under lockdown represent about 19.3% of China's total gross domestic product, equivalent to the size of India's economy but down from 25.1% last Monday.
This marks the first decline in Nomura's closely watched China lockdown index since early October.
Meanwhile, officials continue to play down the dangers posed by the virus, bringing China closer to what other countries have been saying for more than a year as they dropped restrictions and opted to live with the virus, even as it spread.
China's management of the disease may be downgraded as soon as January, to the less strict Category B from the current top-level Category A of infectious disease, Reuters reported on Monday.
"The most difficult period has passed," the official Xinhua news agency said in a commentary on Monday, citing the weakening pathogenicity of the virus and efforts to vaccinate 90% of the population.
Analysts predict China may reopen the economy and drop border controls sooner than expected next year, with some seeing it fully open in spring.
But more than half of Chinese say they will put off travel abroad even if borders reopen now, according to a survey of 4,000 consumers by consultancy Oliver Wyman.
But for all those wary of returning to normality, there are others clamouring for more freedoms.
"Let's implement these policies quickly," a Beijing-based lawyer surnamed Li wrote on WeChat, reacting to the dropping of testing requirements.
"Our lives and work have been affected for so long."
Reporting by Ryan Woo, Martin Quin Pollard, Bernard Orr, Sophie Yu and the Beijing newsroom; Writing by John Geddie and Greg Torode; Editing by Simon Cameron-Moore and Edmund Klamann
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.